[1]全国结核病流行病学抽样调查技术指导组, 全国结核流行病学抽样调查办公室.2000年全国结核病流行病学抽样调查报告[J].中国防痨杂志, 2002,24(2):65.[2] Ramaswamy S, Musser JM. Molecular genetic basis ofantimicrobialagentresistancein Mycobacterium tuberculosis : 1998 update[J]. Tuber Lung Dis, 1998,79(1): 3-29.[3] 中国防痨协会基础专业委员会. 结核病诊断实验室检验规程[M]. 北京:中国教育文化出版社,2006:49-51.[4] Dalla Costa ER, Ribeiro MO, Silva MS, Arnold LS, Rostirolla DC, Cafrune PI, Espinoza RC, Palaci M, Telles MA, Ritacco V, Suffys PN, Lopes ML, Campelo CL, Miranda SS, Kremer K, da Silva PE, Fonseca Lde S, Ho JL, Kritski AL, Rossetti ML. Correlations of mutations inkat G,oxy R- ahp C andinh A genes andin vitrosusceptibility inMycobacterium tuberculosisclinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America[J]. BMC Microbiol, 2009, 9:39.[5] Cho EH, Bae HK, Kang SK, Lee EH. Detection of isoniazid and rifampicin resistance by sequencing ofkat G,inh A, andrpo B Genes in Korea[J]. Korean J Lab Med, 2009,29(5): 455-460.[6] Abdelaal A, El-Ghaffar HA, Zaghloul MH, El Mashad N, Badran E, Fathy A. Genotypic detection of rifampicin and isoniazid resistantMycobacterium tuberculosisstrains by DNA sequencing: a randomized trial[J]. Ann Clin Microbiol Antimicrobi, 2009,8:4.[7] Ramaswamy SV, Dou SJ, Rendon A, Yang Z, Cave MD, Graviss EA. Genotypic analysis of multidrug-resistantMycobacterium tuberculosisisolates from Monterrey, Mexico[J]. Med Microbiol, 2004,53(2): 107-113.[8] Sajduda A, Brzostek A, Poplawska M, Augustynowicz-Kopec E, Zwolska Z, Niemann S, Dziadek J, Hillemann D. Molecular characterization of rifampin- and isoniazid-resiatantMycobacterium tuberculosisstrains isolated in Poland[J]. J Clin Microbiol, 2004,42(6): 2425-2431.[9] Guo JH, Xiang WL, Zhao QR, Luo T, Huang M, Zhang J, Zhao J, Yang ZR, Sun Q. Molecular characterization of drug-resistantMycobacterium tuberculosisisolates from Sichuan province in China[J]. Jpn J Infect Dis, 2008,61(4): 264-268. [10]Chan RC, Hui M, Chan EW, Au TK, Chin ML, Yip CK, AuYeang CK, Yeung CY, Kam KM, Yip PC, Cheng AF. Genetic and phenotypic characterization of drug-resistantMycobacterium tuberculosisisolates in Hong Kong[J]. J Antimicrobial Chemotherapy, 2007, 59(5): 866-873.[11] Hazbón MH, Brimacombe M, Bobadilla del Valle M, Cavatore M, Guerrero MI, Varma-Basil M, Billman-Jacobe H, Lavender C, Fyfe J, García-García L, León CI, Bose M, Chaves F, Murray M, Eisenach KD, Sifuentes-Osornio J, Cave MD, Ponce de León A, Alland D.Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistantMycobacterium tuberculosis [J]. Antimicrob agents Chemother, 2006, 50(8): 2640-2649.[12] Wilson TM, Collins DM.ahp C, a gene involved in isoniazid resistance of theMycobacterium tuberculosiscomplex[J]. Mol Microbiol, 1996, 19(5):1025-1034.[13] Mokrousov I, Otten T, Vyshnevskiy B, Narvskaya O. Detection ofemb B306 mutations in ethambutol-susceptible clinical isolates ofMycobacterium tuberculosisfrom Northwestern Russia:implications for genotypic resistance testing[J]. J Clin Microbiol, 2002, 40(10):3810-3813.[14] Kim SY, Park YJ, Kim WI, Lee SH, Ludgerus Chang C, Kang SJ, Kang CS. Molecular analysis of isoniazid resistance inMycobacterium tuberculosisisolates recovered from South Korea[J]. Diagn Microbiol Infect Dis,2003, 47(3): 497-502.[15] Mokrousov I, Otten T, Filipenko M, Vyazovaya A, Chrapov E, Limeschenko E, Steklova L, Vyshnevskiy B, Narvskaya O. Detection of isoniazid-resistantMycobacterium tuberculosisstrain by a multiplex allele-specific PCR assay targetingKat G codon 315 variation[J]. Clin Microbiol, 2002, 40(7):2509-2512.[16] Wilson TM, de Lisle GW, Collins DM. Effect ofinh A andkat G on isoniazid resistance and virulence ofMycobacterium bovis [J]. Mol Microbiol, 1995,15(6):1009-1015.[17] Morlock GP, Metchock B, Sikes D, Crawford JT, Cooksey RC.eth A,inh A, andkat G loci of ethionamide-resistant clinicalMycobacterium tuberculosisisolates[J]. Antimicrob Agents Chemother, 2003, 47(12): 3799-3805.[18] Cardoso RF, Cooksey RC, Morlock GP, Barco P, Cecon L, Forestiero F, Leite CQ, Sato DN, Shikama Mde L, Mamizuka EM, Hirata RD, Hirata MH. Screening and characterization of mutations in isoniazid-resistantMycobacterium tuberculosisisolates obtained in Brazil[J]. Antimicrob Agents Chemother, 2004, 48(9): 3373-3381.[19] Leung ET, Ho PL, Yuen KY, Woo WL, Lam TH, Kao RY, Seto WH, Yam WC. Molecular characterization of isoniazid resistance inMycobacterium tuberculosis : identification of a novel mutation ininh A[J]. Antimicrob Agents Chemother, 2006, 50(3): 1075-1078. |